Edwards Lifesciences Corp

مادة اعلانية

Latest Update: 21 Dec 2024 00:59 Abu Dhabi Time.

Market Status: Closed

74.77

USD

0.840

1.14%

Open

73.30

Prev Close

73.93

PX_VOLUME

MARKET CAP (M)

DAY RANGE

72.97 - 75.27

52 WEEKS

58.93 - 96.12

Stock Statistics

Yearly Change

-0.19%

Listed Shares (Million)

654.30

Earnings Multiple

10.71

Average 30-day trading volume

4,454,969.89

Price-to-book ratio

4.57

Earnings Per Share

2.31

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		1,354.40	1,385.90	1,598.20	1,534.10	1,243.40
Gross Profit		1,091.50	1,100.60	1,212.60	1,177.20	992.80
Operating Income		394.30	377.20	437.70	427.20	368.10
Net Income		362.10	366.40	351.00	369.70	334.90
Profit Margin		26.74	26.44	21.96	24.10	26.93

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Revenue	6,004.80	5,382.40
Gross Profit	4,625.00	4,302.00
Operating Income	1,728.60	1,789.20
Net Income	1,399.40	1,521.90
Profit Margin	23.30	28.28

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		12,971.20	10,099.30	9,736.30	9,363.20	9,370.80
Total Liabilities		3,359.80	2,594.70	2,549.90	2,643.80	2,643.70
Total Equity		9,611.40	7,504.60	7,186.40	6,719.40	6,727.10

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Assets	9,363.20	8,292.50
Total Liabilities	2,643.80	2,485.80
Total Equity	6,719.40	5,806.70

Cash Flows Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		351.80	371.50	-53.50	136.60	411.50
Cash From Investing Activities		2,701.70	124.80	63.10	14.10	89.00
Cash From Financing Activities		-976.70	-96.60	61.70	-413.20	-143.30
Net Change in Cash		2,025.30	429.10	81.00	-265.90	366.40

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Cash From Operating Activities	895.80	1,218.20
Cash From Investing Activities	173.80	252.30
Cash From Financing Activities	-711.00	-1,584.50
Net Change in Cash	375.40	-94.80

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

Edwards Lifesciences Corp

إدواردز لايفسيانسز كورب